Transforming growth factor α protects against Fas-mediated liver apoptosis in mice

被引:13
|
作者
Kanda, D [1 ]
Takagi, H [1 ]
Toyoda, M [1 ]
Horiguchi, N [1 ]
Nakajima, H [1 ]
Otsuka, T [1 ]
Mori, M [1 ]
机构
[1] Gunma Univ, Sch Med, Dept Internal Med 1, Maebashi, Gumma 3718511, Japan
关键词
Fas/APO-1/CD95; apoptosis; transforming growth factor alpha; Bcl-xL;
D O I
10.1016/S0014-5793(02)02677-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Fas/Fas ligand interaction plays a crucial role in various liver diseases, and administration of agonistic anti-Fas antibody to mice causes massive hepatic apoptosis and fulminant hepatic failure. Several growth factors have recently been found to function in preventing apoptosis. In this study, we demonstrated that overexpression of transforming growth factor alpha (TGFalpha) has a dramatic protective effect on Fas-mediated hepatic apoptosis at the biochemical and histological levels. Moreover, 85.7% (six out of seven) of TGFalpha transgenic mice survived the lethal liver damage, whereas all wild-type mice died. Expression of Bel-xL, an anti-apoptotic protein, was greatly increased in the transgenic mice. Taken together, our findings suggest that TGFalpha protects against Fas-mediated liver apoptosis in vivo and up-regulation of Bel-xL may participate in protective effect of TGFalpha. (C) 2002 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:11 / 15
页数:5
相关论文
共 50 条
  • [21] RANKL regulates fas expression and fas-mediated apoptosis in osteoclasts
    Wu, XJ
    Pan, G
    McKenna, MA
    Zayzafoon, M
    Xiong, WC
    McDonald, JM
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (01) : 107 - 116
  • [22] Soluble Fas gene therapy protects against Fas-mediated apoptosis of hepatocytes but not the lethal effects of Fas-induced TNF-α production by Kupffer cells
    Matsuki, Y
    Li, L
    Hsu, HC
    Yang, PA
    Zheng, R
    Edwards, CK
    Chaudry, IH
    Zhang, HG
    Mountz, JD
    CELL DEATH AND DIFFERENTIATION, 2002, 9 (06) : 626 - 635
  • [23] Fas-mediated apoptosis in accelerated graft arteriosclerosis
    Moldovan N.I.
    Qian Z.
    Chen Y.
    Dong C.
    Ying A.
    Hruban R.H.
    Flavahan N.A.
    Baldwin III W.M.
    Sanfilippo F.
    Goldschmidt-Clermont P.J.
    Angiogenesis, 1998, 2 (3) : 245 - 254
  • [24] Fas-mediated apoptosis in acute alcoholic hepatitis
    Tagami, A
    Ohnishi, H
    Moriwaki, H
    Phillips, M
    Hughes, RD
    HEPATO-GASTROENTEROLOGY, 2003, 50 (50) : 443 - 448
  • [25] A NOVEL ANTI-APOPTOSIS SERUM FACTOR THAT DOWN-REGULATES FAS-MEDIATED APOPTOSIS
    KIKUCHI, H
    SUGIYAMA, S
    IMAJOHOHMI, S
    JOURNAL OF BIOCHEMISTRY, 1995, 117 (05) : 936 - 939
  • [26] Potentiation of Fas-mediated apoptosis by an engineered glycosylphosphatidylinositol-linked Fas
    P Legembre
    P Moreau
    S Daburon
    J-F Moreau
    J-L Taupin
    Cell Death & Differentiation, 2002, 9 : 329 - 339
  • [27] Potentiation of Fas-mediated apoptosis by an engineered glycosylphosphatidylinositol-linked Fas
    Legembre, P
    Moreau, P
    Daburon, S
    Moreau, JF
    Taupin, JL
    CELL DEATH AND DIFFERENTIATION, 2002, 9 (03) : 329 - 339
  • [28] Epidermal growth factor inhibits Fas-mediated apoptosis in salivary epithelial cells of patients with primary Sjogren's
    Nakamura, H.
    Kawakami, A.
    Ida, H.
    Koji, T.
    Eguchi, K.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (06) : 831 - 837
  • [29] Lysosornes and Fas-mediated liver cell death
    Wattiaux, Robert
    Coninck, Simone Wattiaux-De
    Thirion, Jacqueline
    Gasingirwa, Marie-Christine
    Jadot, Michel
    BIOCHEMICAL JOURNAL, 2007, 403 (89-95) : 89 - 95
  • [30] Inhibition of Fas-mediated apoptosis by antigen: Implications for lymphomagenesis
    Schattner, EJ
    Friedman, SM
    Casali, P
    AUTOIMMUNITY, 2002, 35 (04) : 283 - 289